Study examines the accuracy and reliability of virtual cognitive assessments for diagnosing dementia

NewsGuard 100/100 Score

Virtual care provided through telephone or videoconference has been broadly implemented in recent months because of the COVID-19 pandemic.

A new analysis of published studies has examined the accuracy and reliability of virtual compared with in-person cognitive assessments for diagnosing dementia or mild cognitive impairment.

The analysis, which is published in the Journal of the American Geriatrics Society, included 121 studies. Three studies comparing videoconference with in-person cognitive assessments demonstrated good reliability and accuracy of virtual cognitive assessments in diagnosing dementia. Investigators did not identify any studies comparing telephone with in-person cognitive assessments.

The analysis also allowed the researchers to identify virtual cognitive test cut-offs suggestive of dementia or mild cognitive impairment, as well as barriers to implementing cognitive assessments for older adults.

Our results highlight serious knowledge gaps and challenges associated with implementing virtual care for older adults--especially when you consider that the majority of older adults continue to access virtual care via the telephone."

Jennifer A. Watt, MD, PhD, Study Lead Author, St. Michael's Hospital-Unity Health Toronto, Canada

Source:
Journal reference:

Watt, J. A., et al. (2021) Diagnostic accuracy of virtual cognitive assessment and testing: Systematic review and meta‐analysis. Journal of the American Geriatrics Society. doi.org/10.1111/jgs.17190.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals increased risk of allergic diseases after COVID-19 infection